5-Amino-1MQ Protocol: How to Cycle It, Timing & What to Expect

Protocol snapshot

• Typical cycle length: 4 to 6 weeks on, 2 to 4 weeks off; experienced users sometimes extend to 8 to 12 weeks with a proportionally longer break
• Frequency: Once daily (morning) or split twice daily; morning dosing strongly preferred regardless of frequency
• Common delivery routes: Oral capsule; subcutaneous injection
• Key timing notes: Morning dosing is critical; evening or midday dosing is the leading cause of insomnia with this compound

Who This Protocol Is For

5-Amino-1MQ sits in a specific lane. It is not a general wellness compound or a broad performance enhancer. The people who seek out a 5-Amino-1MQ protocol are almost always focused on body composition, and more specifically on metabolic fat loss when other approaches have stalled.

The most common goals are stubborn fat loss, particularly in the midsection and lower back, and the preservation of lean muscle during a cut. It is also used in anti-aging contexts, where its role in supporting NAD+ (a molecule your cells use to produce energy) metabolism and mitochondrial function (the energy-generating work done inside your cells) makes it attractive alongside other longevity-focused compounds. Some users run it specifically to address what feels like a stalled metabolism, using its mechanism to restore a more active cellular energy state.

One finding that appears consistently across user reports is worth flagging early: the compound seems to deliver its most noticeable fat-loss results for people who are already relatively lean. Users carrying significant fat mass have reported little visible change until they drop below a certain body composition threshold. That does not mean it has no effect at higher body fat levels, but it does mean expectations should be calibrated to where you are starting.

Experience level shapes protocol design here in a specific way. Because 5-Amino-1MQ is available in two meaningfully different delivery formats with different bioavailability and dose levels, someone approaching it for the first time is typically steered toward starting conservatively regardless of route, giving the body a day or two to establish tolerance before moving to the full maintenance pattern.

It is also worth knowing upfront that this is not technically a peptide. 5-Amino-1MQ is a small-molecule NNMT inhibitor, which is why it is available in oral capsule form alongside the injectable option. That distinction matters for protocol design because the two routes are not interchangeable on a one-to-one basis.

5-Amino-1MQ is not FDA-approved for human use, and it is banned under the WADA S0 category for athletes subject to anti-doping regulations.

How Is a 5-Amino-1MQ Cycle Structured?

A 5-Amino-1MQ cycle has a clear arc: a brief tolerance-establishing phase at the start, a longer maintenance phase that carries through the bulk of the cycle, and then a deliberate off-cycle break before the next round. Most protocols run four to six weeks on and two to four weeks off. Experienced users who want to push toward peak effects sometimes extend the on-cycle phase to eight to twelve weeks, with a correspondingly longer break afterward.

The off-cycle break is not optional. It is built into the protocol for a specific reason: the body adapts to NNMT inhibition after four to six weeks of daily use, and that adaptation blunts the compound's effectiveness. The break allows the enzymatic system (the set of proteins your body uses to regulate this metabolic process) to reset, which is why many users describe a noticeable second wave of effectiveness when they restart. Think of it like pulling a rubber band back before releasing it. Continuous use without breaks removes the tension; the breaks restore it.

Most sources suggest two to three cycles per year as a sustainable pattern, making this a compound that works in defined windows rather than as a year-round protocol. Starting a cycle at the beginning of a cutting phase or a metabolic reset period is the timing most often described as optimal, where the metabolic activation aligns with an active diet and training strategy.

How Your Dose Is Determined

What moves a 5-Amino-1MQ dose:

• Your goal: Fat loss and metabolic enhancement sit toward the standard maintenance range for this compound, while anti-aging or general NAD+ support protocols sometimes run at the more conservative end. The specific target shapes whether a conservative or fuller approach is appropriate.
• Experience level: First-time users across both routes start lower during the initial tolerance phase before settling into the maintenance pattern. More experienced users who have already established their individual response have a clearer sense of where they land within the range.
• Delivery route: This is the most significant dose lever for 5-Amino-1MQ. Oral capsules have meaningfully lower bioavailability than the injectable route, meaning a substantially higher nominal dose is needed to achieve comparable effect. The two routes operate in entirely different dose ranges, which is a key reason personalization matters here. Injectable protocols are also subject to a practical volume limit per injection site, which caps how high the subcutaneous route can realistically go before oral becomes the appropriate format.
• Individual response: The variability in user-reported experience with this compound is notable. Some users notice metabolic changes within the first week once at the maintenance level; others take two to three weeks to feel a clear shift. That variability argues for a conservative start and an honest assessment of response before any adjustment.

There is a genuine discrepancy in the literature between different dose frameworks for the injectable route. Some clinic-adjacent sources describe a much lower end of the range, while performance-oriented community protocols operate at a considerably higher level. The pharmacological reasoning behind this discrepancy, specifically around what dose is needed to achieve meaningful NNMT inhibition (blocking an enzyme that normally slows your metabolism), is part of what makes personalized guidance genuinely important for this compound rather than something a rough estimate can safely handle.

Your dose should not be a guess. The MyPeptidePal Protocol Creator takes your goal type, your preferred delivery route (oral or injectable), and whether you plan to dose once or split twice daily, and builds your 5-Amino-1MQ protocol: your dose, your cycle, and your timing.

Get your protocol at mypeptidepal.ai

How Often Do You Take 5-Amino-1MQ?

The most common frequency pattern is once daily, taken in the morning. Morning administration is strongly preferred across nearly every source, and the reason is practical: 5-Amino-1MQ produces metabolic activation that disrupts sleep in a meaningful percentage of users when taken in the afternoon or evening. Shifting the dose to morning sidesteps this almost entirely.

Some protocols use a split twice-daily pattern, which the compound's plasma half-life supports. The half-life runs roughly three to seven hours, meaning a single morning dose may not sustain meaningful NNMT inhibition through the full day. A split between a morning dose and an early afternoon dose extends coverage. If you use this approach, the later dose should still be early enough in the day to avoid sleep interference. This is one of the places where route and individual schedule intersect, because the split pattern is more practical for oral capsules than for the injectable format in some contexts.

A small number of clinic protocols use five days on and two days off each week rather than daily dosing, primarily as a matter of patient preference rather than pharmacological necessity. Daily dosing is the more widely used standard.

Loading and Maintenance Phases

The loading phase for 5-Amino-1MQ is brief and is better described as a tolerance check than a traditional loading period. During the first one to two days of a new cycle, users take the compound once daily at a lower level than the full maintenance dose. The purpose is straightforward: assess how the body responds before committing to the full daily maintenance pattern. This is not about priming a receptor or building up tissue levels; it is about confirming that side effects like nausea, fatigue, or GI disturbance are manageable before stepping into the sustained phase.

After those first one to two days, the protocol moves into the maintenance phase, which is the bulk of the cycle. The dose stays consistent throughout this phase rather than escalating week over week. Think of it as finding the right gear and holding it, rather than continuously shifting up. For oral users, that means a consistent daily dose taken once or in a morning and midday split. For subcutaneous users, a once-daily morning injection is the standard maintenance pattern, with the split option available for those who prefer extended coverage.

The maintenance phase runs through the rest of the on-cycle period, typically four to six weeks total from day one. There is no taper at the end of the cycle. The standard approach is to complete the cycle and move directly into the off-cycle break, allowing the enzymatic reset to happen on its own timeline.

Off-Cycle Considerations

The off-cycle period is one of the most structurally important parts of a 5-Amino-1MQ protocol. Unlike some compounds where the break is simply a precaution, here it is directly tied to how the mechanism works. The body's NNMT pathway adapts to sustained inhibition over time, reducing the effectiveness of continued use. A deliberate break allows NNMT activity to rebound and the enzymatic system to normalize, restoring the compound's impact when the next cycle begins.

A standard break runs two to four weeks following a four to six week on-cycle. Users running longer cycles of eight to twelve weeks typically take proportionally longer breaks, in the range of four to six weeks off. These patterns appear most consistently across real-world protocols and align with the physiological rationale: the longer the on-cycle, the more time the system needs to fully reset.

There is no withdrawal effect or requirement to taper before the break. The cycle ends, the break begins, and the next cycle starts when the off-period is complete. Many users choose to time the start of a new cycle with a renewed diet phase or a shift in training focus, reinforcing the metabolic momentum that the compound supports.

What to Expect Week by Week

• Week 1 to 2: The first week is often quiet. Many users report minimal noticeable changes early on, particularly during the tolerance phase. By the end of week two, once the full maintenance pattern is established, the most commonly reported first sign is a shift in energy: cleaner and more sustained than usual, frequently compared to strong coffee without the jitters. Some also notice improved workout quality and mild digestive changes. Fat loss effects are rarely visible this early.

• Week 3 to 4: This is where most users describe the protocol beginning to produce tangible results. Energy becomes more consistent throughout the day, and metabolic changes start to be perceptible in body composition, particularly in the midsection and lower back. Appetite suppression is commonly reported in this window. For users who are already relatively lean, visible changes in muscle definition and fat distribution are often first noticed here.

• Week 5 to 8: Users running longer cycles describe this as the peak effectiveness window. Fat oxidation effects are most pronounced, and lean tissue is generally preserved, particularly when strength training and adequate protein intake are part of the picture.

• Beyond 8 weeks: For users running extended protocols of eight to twelve weeks, this range is where the compound tends to produce its most meaningful body composition changes. It is also the window where pathway adaptation begins to accelerate, which is why the off-cycle break that follows an extended cycle is correspondingly longer.

Here is what a well-run cycle commonly looks like when it goes right. A user who is already in reasonable shape runs a consistent four to six week cycle with morning dosing, a clean diet, and active training. They exit with noticeably reduced fat in the stubborn areas that resisted other approaches, maintained lean mass, and sustained energy through the cut rather than the flatness that aggressive caloric restriction typically produces. That is the realistic arc of a successful cycle as commonly described across user reports. It is not a guarantee, and individual results vary by route, starting body composition, consistency, and how well the cycle aligns with diet and training.

Common Protocol Mistakes

Evening or afternoon dosing. This is the single most frequently cited mistake in user reports. 5-Amino-1MQ produces metabolic activation that translates directly into disrupted sleep for a significant share of users when taken after midday. The fix is simple: all dosing, whether once daily or split, belongs in the morning. If using a split pattern, the later administration should be early enough in the day to clear the system before sleep.

Skipping the tolerance phase. The first one to two days at the lower starting level exist for a reason. Users who jump directly to the full maintenance dose on day one are more likely to experience pronounced nausea, fatigue, or GI disturbance. A brief tolerance phase costs almost nothing and significantly smooths the transition.

Continuous use without cycling off. Running 5-Amino-1MQ without breaks is one of the clearest ways to produce diminishing returns. The pathway adaptation that sets in after four to six weeks of continuous use is predictable. The off-cycle break is mechanistically necessary for the compound to remain effective across multiple cycles.

Mismatching the route to the dose level. There is a practical volume limit for subcutaneous injection per site. When the target dose reaches the upper range of the injectable format, the injection volume becomes too large for a single site, and at that level the oral route is the appropriate format. This is a common error among users new to the injectable format.

Doubling up after a missed dose. Taking a double dose the following morning after missing a day is counterproductive. The appropriate approach is to skip the missed dose and resume the normal morning dose the next day. The compound's mechanism does not benefit from compensatory loading.

Expecting visible fat loss at high body fat levels. The body composition threshold for noticeable fat-loss effects is one of the most consistent findings in user reports. Setting realistic expectations for where the compound delivers its most pronounced effect prevents frustration and early abandonment.

Poor source verification. As a research compound without regulatory oversight of commercial sources, product quality varies substantially. Using a source without third-party testing or any verifiable manufacturing standard is a meaningful risk. Concentration and purity directly affect both safety and whether any protocol-level effect is achievable.

Frequently Asked Questions

How long is a typical 5-Amino-1MQ cycle?

Most protocols run four to six weeks on, followed by a two to four week off-cycle break. Experienced users sometimes extend the on-cycle phase to eight to twelve weeks, with a proportionally longer break afterward. Cycle length is one of the variables the MyPeptidePal Protocol Creator personalizes based on your goal and experience level.

How often do you take 5-Amino-1MQ?

Once daily in the morning is the most common pattern across real-world protocols. Some users split the daily dose into a morning and early afternoon administration, which the compound's short plasma half-life supports for more sustained coverage. Evening dosing is consistently flagged as the primary cause of insomnia with this compound and should be avoided regardless of frequency pattern.

Does 5-Amino-1MQ need a loading phase?

It uses a brief one to two day tolerance-establishing phase at the start of each cycle rather than a traditional loading period. The purpose is to assess individual response before moving to the full maintenance dose, not to build tissue levels. After those first couple of days, the dose stays consistent through the rest of the cycle.

Do you need to cycle off 5-Amino-1MQ?

Yes, and this is one of the most structurally important aspects of the protocol. The body adapts to sustained NNMT inhibition after four to six weeks, reducing the compound's effectiveness. The off-cycle break allows the enzymatic system to reset and is directly tied to why the compound continues to work across multiple cycles rather than losing effect over time.

Is 5-Amino-1MQ actually a peptide?

No. Despite frequent categorization alongside peptide therapies, 5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. This distinction is practically relevant because it is why the compound is available in oral capsule form in addition to the injectable format, and why the dose levels between the two routes differ substantially.

Can 5-Amino-1MQ be stacked with other compounds?

Many users combine it with NAD+ precursors like NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside), both compounds your body converts into NAD+, which is pharmacologically logical given that NNMT inhibition and NAD+ supplementation work through complementary mechanisms on the same pathway. Some users also run it alongside metabolic or recovery-focused compounds. Any stacking decision adds complexity and should be approached with appropriate guidance.

Disclaimer

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world protocols for 5-Amino-1MQ in one place.